clinical trials

August 9, 2023

VUMC receives $51 million in NIH grants to improve efficiency of conducting clinical trials across the US

Vanderbilt researchers have been awarded two five-year federal grants totaling $51 million to harness new and existing approaches for boosting recruitment and removing roadblocks to the efficiency of conducting clinical trials throughout the country.

By Bill Snyder
July 25, 2023

nference and Vanderbilt University Medical Center sign agreement to advance real-world evidence generation in complex disease populations

nference, a science-first software company transforming healthcare by making biomedical data computable, and Vanderbilt University Medical Center have announced a strategic agreement aimed at advancing research through the deployment of nference’s state-of-the-art federated clinical analytics platform. By leveraging the power of federated AI and machine learning, this collaboration will expand clinical insights in key research areas.

By VUMC News and Communications
July 17, 2023

World-first clinical trial to help millions with penicillin allergies

Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.

By Craig Boerner
March 7, 2023

Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center

Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.

By Tom Wilemon
July 21, 2022

VUMC partners with Yale and Morehouse Schools of Medicine, industry organizations to increase diversity in clinical trials

Vanderbilt is partnering with Yale School of Medicine, Morehouse School of Medicine and the Research Centers in Minority Institutions Coordinating Center at the Morehouse School of Medicine in an initiative aimed at increasing diversity in clinical trials and addressing systemic barriers to participation by communities of color.

By Mia Garchitorena-Scancarelli
December 15, 2021

Study finds similar success rates with two devices for breathing tube placement

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA.

By Leigh MacMillan
December 2, 2021

Reid selected for clinical trial development program

Vanderbilt's Sonya Reid, MD, MPH, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.
By Tom Wilemon
November 2, 2021

Shifts in neuroendocrine cancer clinical trial design

Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.
By Leigh MacMillan
October 28, 2021

Reid receives NRG Oncology early-stage investigator award

Vanderbilt's Sonya Reid, MD, MPH, is a recipient of an NRG Oncology Underserved Minority Scholars Award.
By Tom Wilemon
October 14, 2021

STAR Clinical Research Network to receive major grant renewal

Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.
By Bill Snyder
October 14, 2021

Photoimmunotherapy offered in clinical trial for recurrent head and neck cancer

Vanderbilt-Ingram Cancer Center is recruiting patients for a clinical trial using photoimmunotherapy for recurrent head and neck cancer.
By Tom Wilemon
September 23, 2021

Clinical trial tests ATR inhibitor in difficult-to-treat cancers

By Doug Campbell
September 23, 2021

Eng named co-chair of NCI clinical trials steering committee

Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.
By Tom Wilemon
1 2